What happens when your lab's core platform can't be replaced, but it also can't stay the same? That's the position most genetic testing labs eventually land in.
The system that ran the lab for a decade starts running out of runway: onboarding a new hospital takes three weeks instead of three days, order search slows down as sample volume grows, and every small report change needs a developer. Nobody decided to fix it. The system just stopped keeping up.
The catch is that a CLIA-certified or CAP-accredited lab can't pause operations to rebuild it. A rushed migration in a live clinical environment isn't just downtime. It's a compliance event, a revenue event, and potentially a patient-care event, all at once.
So the real question isn't should we replace it. It's how do we replace it without ever having to stop?
Key Takeaways
- The average cost of a single hour of downtime now exceeds $300,000 for more than 90% of mid-size and large enterprises, and healthcare is one of the highest-cost verticals measured (ITIC 2024 Hourly Cost of Downtime Survey)
- A full "big bang" cutover, replacing the legacy system in one release, is the highest-risk path for a system that touches CLIA and CAP-regulated operations, because there's no partial rollback if something breaks in production
- The alternative is a phased architecture pattern known as the strangler fig approach: new components are built alongside the legacy system, and traffic is redirected feature by feature, with the old system still running until every piece has been replaced (Martin Fowler, 2004, martinfowler.com)
- NonStop has rebuilt a genetic testing lab's order, reporting, and billing platform off a decade-old monolith this way, one surface at a time, while the lab kept processing clinical orders throughout
What Actually Happens When a Genetic Testing Lab Tries to Replace Its Legacy LIS?
Most legacy LIS and lab platform replacements fail the same way: the team scopes a full rebuild, sets a cutover date, and discovers during testing that dozens of small workflows depended on undocumented behavior in the old system. Order search performance, custom report templates, billing edge cases built up over a decade, none of it is written down anywhere except in the code itself.
Under CLIA and CAP requirements, any new system or workflow change affecting patient results has to be validated before it goes live, not after. That validation burden gets much harder when the whole platform changes at once, because there's no way to isolate which change caused which regression. A phased approach keeps the validation scope small and traceable, one component at a time, instead of one enormous release that has to be trusted all at once.
How Much Does Unplanned Downtime Actually Cost a Genetic Testing Lab?
Downtime cost isn't hypothetical. Independent research firm ITIC's 2024 Hourly Cost of Downtime Survey, based on responses from over 1,000 organizations worldwide, found that the average cost of a single hour of downtime exceeds $300,000 for more than 90% of mid-size and large enterprises, with healthcare ranked among the highest-cost verticals measured (ITIC, 2024).
For a genetic testing lab, that cost isn't only the hour itself. A stalled order queue during migration means delayed results for patients waiting on time-sensitive diagnoses, referring physicians who lose confidence in turnaround time, and a CAP inspection trail that now has to explain an unplanned outage. The migration risk and the operational risk are the same risk, not two separate ones.
Common Failure Modes in Legacy LIS Migrations
Most failed migrations don't fail because the new system was built wrong. They fail because the team underestimated what the old system was actually doing. Three patterns show up again and again in genetic testing lab modernization projects, and all three are avoidable with the right approach.
Undocumented business logic
A decade-old LIS accumulates business rules that were never written down anywhere except in the code itself, often in stored procedures, cron jobs, or custom scripts that predate the current engineering team entirely. A billing edge case for a specific insurance payer, a report formatting exception for one referring physician group, a validation rule added after a specific CAP finding years ago: none of it shows up in a requirements document, because nobody wrote a requirements document. The team discovers it exists only when a workflow breaks during testing, or worse, after go-live. A phased migration surfaces this logic one component at a time, so a missed edge case in order search doesn't take down billing at the same time.
CLIA validation scope expanding mid-project
A migration that starts as "replace the reporting module" can quietly expand once the team realizes reporting touches order data, which touches billing codes, which touches the audit trail CAP inspectors expect to see. Under a big-bang cutover, that scope creep happens invisibly until the validation plan no longer matches what actually shipped. Under a phased approach, each component's validation scope is defined before that component starts, and expanding scope means adding a new phase, not silently expanding the one already in flight.
Rollback failures
The theoretical safety net of a big-bang cutover is "if it breaks, we roll back." In practice, a full rollback of a live clinical system, after days or weeks of new orders, results, and billing events have already been processed on the new platform, is rarely clean. Data written to the new system has to be reconciled back into the old one, and that reconciliation itself becomes a second high-risk event on top of the failed cutover. A phased migration avoids this entirely: each component runs in parallel with its legacy counterpart before traffic fully switches over, so the "rollback" is just routing traffic back to a system that was never turned off.
Is a Full Replacement Ever the Right Approach?
Sometimes. A small, low-dependency internal tool with no regulatory exposure can often be replaced in one release without much risk. A core LIS handling live patient orders, results, and billing for a CLIA-certified or CAP-accredited lab is a different category of system entirely.
The pattern that consistently reduces risk for systems like this is the strangler fig approach, a term coined by software architect Martin Fowler in 2004. New functionality is built alongside the legacy platform, and a routing layer directs traffic to the new component once it's validated, while everything not yet migrated keeps running on the old system. The legacy system is never turned off in one step. It's replaced piece by piece until nothing depends on it anymore, and then it's decommissioned.
What Does Zero-Downtime Migration Actually Look Like in Production?
NonStop rebuilt a genetic testing lab's order, reporting, and billing platform off a decade-old monolith using exactly this approach: one surface migrated at a time, with the legacy system still processing live clinical orders throughout. No downtime window. No single cutover date the whole lab had to brace for.
The legacy system was a decade-old monolithic LIS built on a PHP backend with a MySQL database, running on on-premise servers. There was no API layer: every integration was point-to-point. Report templates were hardcoded. Adding a new hospital required a developer to manually configure the account in the database. Business logic lived in stored procedures that nobody on the current team had written.
Phase 1: Order Search
Order search was migrated first. It was the highest-traffic, most user-facing component and the clearest performance bottleneck: a full-text search across 70,000+ records running on a relational database not designed for it. It was extracted, rebuilt on Elasticsearch, run in parallel with the legacy search for two weeks to validate result parity, then traffic was routed to the new component. The legacy search path stayed live as fallback for another month before being retired. Total time for this one component: six weeks.
Phase 2: Hospital Account Onboarding
Hospital account onboarding came next, the second biggest operational pain point. The legacy process required manual database entries across five tables. The new onboarding flow was built as a standalone service with its own API, connected to the legacy system via an integration layer that kept both in sync during the transition. Onboarding time dropped from three weeks to under three days within the first month of the new service going live.
Total migration timeline: fourteen months from first component to full decommission of the legacy system. The lab processed clinical orders throughout with zero unplanned downtime during the entire migration period.
The technical mechanics matter here, not just the outcome. Each component was extracted, rebuilt, and run in parallel with its legacy counterpart before traffic was routed to it, so any regression showed up against a working baseline instead of in production with no fallback. Order search, one of the highest-traffic paths in the system, was migrated this way and validated against real query patterns before the old search path was retired. The new platform was designed to meet HIPAA Security Rule technical safeguards (audit controls, access management) while separately satisfying CLIA/CAP validation and audit-trail requirements. Since retrofitting compliance into a system already in production is far more expensive than designing for it upfront.
This is the same approach relevant to any HIPAA-compliant LIS for US clinical labs undergoing modernization: the compliance and validation requirements don't pause for a migration, so the migration has to work around them instead of the other way around.
What Actual Results Come Out of a Migration Like This?
Order search across 70,000 records went from a multi-second wait to about 20 milliseconds. New hospital account onboarding, previously a multi-week process, dropped to days. Feature delivery speed roughly doubled, and none of it required a disruption window because nothing was ever fully offline during the transition.
None of these numbers came from a single big release. They came from a sequence of smaller, validated changes, each one shipped without the lab having to stop taking orders to accommodate it. That's the actual difference between a modernization project that works and one that becomes a multi-year initiative everyone is afraid to finish.
Frequently Asked Questions
How long does a zero-downtime legacy LIS migration typically take?
It depends on the size and complexity of the legacy platform, but phased migrations are measured in months of incremental releases rather than a single cutover date. The tradeoff is a longer overall timeline in exchange for a working system at every step instead of one high-risk event.
Does a phased migration cost more than a full rebuild?
Often less, once the cost of validation, rollback risk, and potential downtime is included. A full rebuild concentrates all of that risk into one release; a phased migration spreads it out and lets the lab catch problems while the blast radius is still small.
Can this approach work for a lab that's never done a platform migration before?
Yes. The phased approach is specifically designed to reduce the operational maturity required, since the lab's team never has to manage a full cutover, only a series of smaller, lower-risk changes.
How does a phased migration handle CLIA validation requirements?
Each component gets its own validation scope, defined before that component starts, rather than one validation plan trying to cover the entire platform at once. That means a CAP inspector or internal quality reviewer can trace exactly which change was validated, when, and against what evidence, one component at a time, instead of reconstructing a validation trail for a single massive release after the fact. It also means a validation finding on one component doesn't stall the rest of the migration.
What is the role of API layers and routing in a strangler fig migration?
The routing layer is what makes the migration reversible at every step. Instead of a hard switch from old system to new, a routing layer sits between users and both systems, directing traffic to the new component once it's validated and able to fall back to the legacy path if something goes wrong. Building a clean API layer around each new component also solves a second problem common in legacy labs: the old system often has no API at all, just point-to-point integrations, so the migration is also the first time the platform gets an integration layer other systems can actually build on.
Modernize Without Stopping
A legacy platform that's already slowing down onboarding, search, and feature delivery doesn't get easier to replace by waiting. It gets more expensive, and the gap between what the lab needs and what the system can do keeps widening. If this sounds like where a lab's platform is heading, a 15-minute scoping call with NonStop's team is a low-pressure way to find out what a phased migration would actually look like for that specific system.
References
Mahendra works as a Sr. Bioinformatics Engineer at NonStop. He builds genomic pipelines, agentic AI systems, and AI-powered products for genomics and life sciences. He has 10+ years of experience in bioinformatics and genomics software. He studied Biotechnology at Mumbai University.